Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Colorado for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Colorado only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Colorado (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Adam Martidis (NPI 1881697910)

Field	Value
Entity Type	Individual
Organization	Adam Martidis
Address	2770 N Union Blvd Ste 140
City	Colorado Springs
State	CO
ZIP	80909
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	May 23, 2005

Payer Source	Total Paid
Medicare	$3.4M
Medicaid	$0

Key Findings

This provider is operating as a retina-focused ophthalmology practice centered on intravitreal biologic therapy and diagnostic imaging. The top three Medicare revenue drivers are J2777 ($2.1M), J2778 ($410.5K), and J0178 ($403.7K), and the CPT mix also includes high volumes for retinal imaging such as 92134 (2.7K claims, $87.3K revenue) and angiography 92235 (540 claims, $59.4K revenue), which together point to a practice model built around repeated injection visits supported by multimodal retinal diagnostics.

Medicare revenue is highly concentrated: the precomputed top-3 codes account for 83.8% of total Medicare revenue, and a single code, J2777, contributes 60.1% of Medicare revenue ($2.1M). This concentration indicates the practice’s financial performance is heavily dependent on intravitreal faricimab administration.

Payer mix is effectively single-payer at present — Total Medicare revenue is $3.4M and there is no Medicaid billing on file. The absence of Medicaid activity implies the provider’s Medicare experience drives nearly all observed public-payer volume and revenue.

On competitive standing, the provider is a national high-volume participant for several services: J2777 ranks #48 of 2039 providers nationally (98th percentile; notably above typical national volume), 92134 ranks #534 of 26868 providers (98th percentile; extreme outlier, far above typical national volume), and 92014 ranks #1711 of 35415 providers (95th percentile; notably above typical national volume). These rankings indicate the provider is well above typical national volumes for both injection therapy and retinal imaging, marking them as a major volume source for those services.

Not all high-revenue drugs show the same market position: J2778 (2.3K claims, $410.5K revenue) ranks #181 of 1208 providers (85th percentile; typical, unremarkable volume) and J0178 (598 claims, $403.7K revenue) ranks #1777 of 3204 providers (44th percentile; typical, unremarkable volume). In other words, the provider’s dominance is most pronounced for J2777 while other anti-VEGF agents appear at more routine volumes relative to national peers.

Surgical retinal procedures are present but limited in scale: 67042 (23 claims, $19.8K revenue) and 67036 (26 claims, $18.6K revenue) show modest surgical case counts and rank in mid-to-lower percentiles, and 67108 (12 claims, $10.9K revenue) is also low-volume. This pattern reinforces that the practice is primarily medical-retina/injection-focused rather than a high-volume vitreoretinal surgical center.

The provider reports unusually high volume for certain E/M and diagnostic services: 99204 (222 claims, $25.5K revenue) ranks #3556 of 227068 providers (98th percentile; extreme outlier, far above typical national volume) and 92235 ranks #74 of 2192 providers (97th percentile; notably above typical national volume). Elevated volumes of high-complexity new patient visits and angiography suggest substantial referral-driven diagnostic throughput in support of the injection/service-line.

The provider has a long-tenured enrollment history, with NPI enumerated on 2005-05-23 (~21 years ago), which supports interpretation of the observed volume patterns as established practice behavior rather than a short-term fluctuation. Combined with the concentrated revenue mix and high national percentiles on key retina codes, this tenure suggests sustained specialization in intravitreal therapy and retinal diagnostics.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

17 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J2777	Injection, faricimab‑svoa, 0.1 mg	71,040	$30	$2.1M
J2778	Injection, ranibizumab, 0.1 mg	2,310	$180	$410.5K
J0178	Injection, aflibercept, 1 mg	600	$680	$403.6K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,820	$100	$186.9K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	990	$90	$91.6K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	2,730	$30	$87.3K
92235	The provider uses a special dye, fluorescein that causes the blood vessels in the one or both eyes to stand out in photographic images taken with the use of multiframe timing, or serial images, taken…	540	$110	$59.4K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	220	$120	$25.5K
67042	In this procedure, the provider removes vitreous humor, the gelatinous material that gives shape to the eye, using a mechanical cutting tool. He removes the internal limiting membrane of the retina…	20	$860	$19.8K
67036	The provider removes vitreous fluid from the eye to access the posterior segment of the eye and introduce surgical instruments through incisions in the pars plana.	30	$710	$18.6K

Showing 1–10 of 17

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 17 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Colorado Distribution

Adam Martidis — 5 of 17 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Colorado

Full comparison — all codes billed, vs. state median

17 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	33	60	740	$690	$618.3K
J2777	2	40	8,910	$30	$456.1K
J2778	4	20	600	$180	$199.7K
67028	5	80	670	$100	$73.3K
J7312	8	10	220	$160	$37.4K
67036	11	30	20	$1,100	$37.3K
67042	12	30	20	$1,140	$29.6K
67108	17	20	20	$1,260	$26.5K
J7999	26	50	230	$70	$21.5K
Q5124	1	10	100	$170	$16.4K

Showing 1–10 of 17

Related Providers

Other providers that share a Tax Identification Number (TIN) with Adam Martidis, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Retina Consultants Of Southern Colorado P C	CO	Ophthalmology Physician	$0	$9M
James Luu	CO	Retina Specialist (Ophthalmology) Physician	$4.1M	$0
Ramin Sarrafizadeh	CO	Retina Specialist (Ophthalmology) Physician	$3.4M	$0
Ryan Rich	CO	Ophthalmology Physician	$3.1M	$0
Stanford Taylor	CO	Retina Specialist (Ophthalmology) Physician	$2.7M	$0
Cecinio Ronquillo	CO	Ophthalmology Physician	$2.1M	$0
David Lazar	CA	Retina Specialist (Ophthalmology) Physician	$1.9M	$0
Stanley Saulny	TX	Ophthalmology Physician	$367.5K	$0
Steven Christiansen	CO	Ophthalmology Physician	$302.9K	$0
Kyle Huynh	CA	Ophthalmology Physician	$284.1K	$2.2K

Nearby Providers

Other providers in the same ZIP code as Adam Martidis, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Voyager Home Health Care LLC	CO	Home Health Agency	$0	$69.7M
Uch-mhs	CO	General Acute Care Hospital	$0	$69M
Rocky Mountain Health Care Services	CO	PACE Provider Organization	$0	$38.5M
Buck Jack LLC	CO	Speech-Language Pathologist	$0	$32.7M
Mountain View Home Care Inc.	CO	In Home Supportive Care Agency	$0	$19.3M
Emergency Medical Specialists, PC	CO	Emergency Medicine Physician	$0	$13.2M
Colorado Domestic Care Inc.	CO	Home Health Agency	$0	$11.6M
Radiology & Imaging Consultants PC	CO	Diagnostic Radiology Physician	$0	$9.5M
Hero Dental Of Springs PC	CO	General Practice Dentistry	$0	$9.3M
Akvc Central LLC	CO	Pediatric Optometrist	$0	$8.8M

Adam Martidis — Billing Profile & Reimbursement Data

Sign up for Adam Martidis — Billing Profile & Reimbursement Data policy alerts

Adam Martidis — Billing Profile & Reimbursement Data

Sign up for Adam Martidis — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References